High Rise: Cannabis MSOs, Products & Market Analysis

In this week's episode, Cy Scott and Emily Paxhia dive deep into the shifting dynamics of the cannabis market. They begin with a closer look at Missouri, where the top 5 local cannabis brands are emerging strong, now accounting for almost 30%. What's fueling this rise, and what does it signify for other regional players?    The discussion then transitions to a recap of the Benzinga Canna...

We are live! Or,  were live for that matter. Cannabis pioneer Kris Krane joins the High Rise at Benzinga in Chicago to reflect on his 25+ year career. He discusses pivotal moments like legalization in 2012 and his shift from advocacy to industry. Krane also provides an insider perspective on dynamics shaping the Illinois market and future growth opportunities. Tune in for a fascinating, in-depth i...

This week, Cy and Emily dive deep into the transformative shifts in the cannabis industry. The much-anticipated SAFE Banking Act is finally approaching a Senate Committee vote, a monumental step in ensuring the industry's legitimacy. But the progress doesn't stop there!    The Cannabis Users’ Restoration of Eligibility (CURE) Act aims to break barriers in federal employment due to mariju...

In this episode, Cy and Emily discuss the shifts in Maryland's cannabis scene. They reference a Brookings Institute study which highlights surprising support for cannabis in the state's November '22 election. Interestingly, even traditionally conservative regions in Maryland backed the move to legalize cannabis, proving that the topic transcends typical political lines. Maryland&apo...

On this episode of the High Rise Cy and Emily decide not to talk too much about the recent news of the U.S. government’s potential move to reschedule cannabis to a schedule III controlled substance. At this point there’s no need to pontificate amongst all of the speculation bouncing around the industry until we get a substantial update from the government…so stay tuned everyone!      Shifting gear...

In this episode of High Rise, Cy and Emily delve into the unfolding narrative of Ohio's imminent cannabis ballot initiative. The hosts unpack the Coalition to Regulate Marijuana Like Alcohol's journey to secure signatures, detailing the suspenseful race against time and the subsequent validation process. They outline the proposed legal framework, including the creation of a Division of C...

On this episode of the High Rise Cy and Emily paint a vivid picture of how cannabis brands are quenching their thirst for beer ventures specifically, Tilray purchasing eight beverage brands from AB/InBev. The discussion explores the implications of this cross-industry relationship on the evolving landscape of both markets. Our hosts also take a quick look into the recent Ohio cannabis legalization...

Join Cy and Emily in an insightful conversation with John Hartmann, the new CEO of Ascend Wellness, as they delve into the dynamic world of leadership, strategy, and growth in the cannabis industry. The discussion takes a deep dive into Ascend Wellness's strategic operations. John shares unique insights gained from spending extensive time at each of the company's dispensaries and cultiva...

Join Cy and Emily on The High Rise as they explore the dynamic landscape of New Jersey's cannabis program. In this episode, they begin by delving into the recent amendments made by the Cannabis Regulatory Commission, prioritizing cannabis licensing for social equity applicants for three months starting September 27. The hosts discuss the implications of these changes, the focus on wholesale,...

In this episode of The High Rise, Cy and Emily provide a comprehensive look at the state of Illinois' cannabis program, exploring recent modifications to 55 new adult-use licenses. Tune in as they discuss the key changes in the licensing process, the use of a lottery system for selecting winners, and the removal of residency requirements and bonus points for military veterans.  Our hosts also...

In this episode of The High Rise, Cy and Emily dive into the intriguing phenomenon of THC inflation in the cannabis industry. They begin by addressing Organigram's recent earnings call, where CEO Beena Goldenberg highlighted the issue of falsely labeled cannabis products with exaggerated THC levels. Shockingly, nearly 50% of cannabis flower sales in Q3 were found to be labeled as containing 2...

In this episode of The High Rise, we delve into the latest news in the cannabis industry regarding a trademark infringement case. Tune in as we discuss the case involving the popular marijuana strain Zkittlez, which recently faced legal pressure from confectioner Wrigley, the owner of the Skittles trademark. Don't miss this episode that sheds light on the evolving landscape of intellectual pr...

Join Cy and Emily as they uncover some of the buzz around Maryland's initial weekend of legal cannabis sales. Plus, get a nice little breakdown on 4th of July sales trends across the U.S. cannabis industry, delving into the evolving dynamics of cannabis consumption that occurs during this festive summertime holiday. Headset

In this episode of The High Rise, Cy and Emily are joined by special guest Mitch Trellis, co-founder of Remedy, a leading retail chain in Maryland. Join them as they dive into an exciting discussion about Maryland's highly anticipated launch into adult-use recreational cannabis. Mitch provides valuable insights into the state's regulatory framework, market dynamics, and the potential imp...

In this episode of The High Rise, Cy and Emily delve into the latest cannabis news and industry updates. They start by discussing the significant development that the U.S. Department of Health and Human Services (HHS) is conducting an administrative review of cannabis scheduling, with plans to present President Joe Biden with a federal cannabis scheduling decision later this year, as revealed by H...

In this episode of The High Rise, Cy and Emily explore the exciting developments surrounding Alabama's upcoming medical marijuana program. Join them as they discuss the state's journey, from the signing of the program into law in 2021 to the preparations for the launch expected this year. Delve into the details of Alabama's medical marijuana program, including the licensing process,...

In this exciting episode of The High Rise, Cy and Emily bring their insights straight from New York City as they delve into the rapidly evolving cannabis market in the state. Joining them is special guest Jeffrey Schultz, an attorney and investor with extensive knowledge of the industry. Together, they explore and analyze the unfolding landscape of the New York cannabis market. From regulatory upd...

In this week's episode of The High Rise, Cy and Emily dive into the latest update on the SAFE Banking Act. Join them as they discuss the recent developments and insights gained from Emily's investigating the hearings in Washington D.C. Get an inside look at the progress and potential impact of the SAFE Banking Act on the cannabis industry. Headset

In this special rerun episode, we're revisiting our conversation with US Representative Nancy Mace from South Carolina. Pulled from the archives, we sit down with Representative Mace to discuss The States Reform Act, a bill she introduced that seeks to remove cannabis as a Schedule I drug. We also dive into her personal journey in the cannabis industry and the potential positive impacts that...

This week on The High Rise, we're discussing recent bank failures and closures and their potential impact on the SAFE Banking Act. As more states legalize cannabis, the need for secure banking solutions for cannabis businesses becomes increasingly pressing. Join Cy and Em for a timely discussion on the latest developments in cannabis banking and the potential impacts on the SAFE Banking Act....

In this week's episode of The High Rise, we're covering 4/20, the unofficial holiday celebrated by cannabis enthusiasts worldwide. Join us as we examine the cultural phenomenon of 4/20 and its impact on the cannabis industry, including exclusive insights into sales numbers from Headset's Insights platform. Don't miss out on this highly informative and fun post 4/20 breakdown. h...

In this week's episode of The High Rise, we're thrilled to welcome back Andrew Carter, Director and Consumer Analyst at Stifel. Andrew joins us to delve into the latest notable moves being made by Canadian cannabis LPs (Licensed Producers) and to provide his expert analysis on these developments. Tune in for an insightful and engaging discussion on the current state and future of the Can...

In this week's episode of The High Rise, we're excited to welcome back Matt McGinley, a Managing Director at Needham & Company and a regular guest host on the show. With his wealth of cannabis industry analysis and financial knowledge, Matt joins Cy and Emily to dive into the latest earnings news from major industry MSOs, as well as insights into the current state and future of the c...

So the market for T-shirts, hats, paintings and even motivational speeches is going to get a lot smaller in Washington D.C. and for good reason! They are finally building out their ‘adult-use’ market. For a city known for its dysfunction, the news this week on the new law around DC shows some meaningful progress.   https://www.marijuanamoment.net/d-c-medical-marijuana-expansion-bill-eliminating-li...

It seems like with each new legal adult use recreational market that opens up, there’s usually some kind of litigation involved—and the state of New York is no exception. On this episode of the High Rise, Cy and Emily shed some light on some of the drama happening in NY and why several major cannabis companies have had it with the way policy makers are trying to run things. https://cannabis.ny.gov...